Continuous growth of mean tumor diameter in a subset of grade II gliomas.
about
ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic StrategiesMalignant Transformation in Glioma Steered by an Angiogenic Switch: Defining a Role for Bone Marrow-Derived CellsGlioma surgery in eloquent areas: can we preserve cognition?Cognition and resective surgery for diffuse infiltrative glioma: an overviewVignettes from the field of mathematical biology: the application of mathematics to biology and medicineAwake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.Estimating Tumor Growth Rates In Vivo.Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2.Microsurgical excisions of vestibular schwannomas: A tumor-size-based analysis of neurological outcomes and surgical complications.Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.Neuroimaging in glioma therapy.Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution.The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Advanced MRI in the management of adult gliomas.Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny.A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis.An image-driven parameter estimation problem for a reaction-diffusion glioma growth model with mass effectsResting functional connectivity in patients with brain tumors in eloquent areas.Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.Plasticity of language pathways in patients with low-grade glioma: A diffusion tensor imaging study.Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patientsProlonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomasDiscriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metricA Molecular Predictor Reassesses Classification of Human Grade II/III GliomasCurrent treatment of low grade gliomasPathological neural attractor dynamics in slowly growing gliomas supports an optimal time frame for white matter plasticityPROX1 is a predictor of survival for gliomas WHO grade IIPhase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma.Imaging of gliomas at 1.5 and 3 Tesla - A comparative study.Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas.Functional rearrangement of the primary and secondary motor cortex in patients with primary tumors of the central nervous system located in the region of the central sulcus depending on the histopathological type and the size of tumor: Examination bIntraoperative cortico-subcortical stimulations in surgery of low-grade gliomas.Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center surveyIncreasing the Time Interval between PCV Chemotherapy Cycles as a Strategy to Improve Duration of Response in Low-Grade Gliomas: Results from a Model-Based Clinical Trial Simulation.'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis.A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle
P2860
Q26747496-8F6DEF56-8863-43C4-8348-021219D65F8EQ26765887-376A4B5C-0189-4D1F-93A9-B4C6172DE74FQ26777165-5CFBBCDA-1732-4A58-BB58-14F38F831A6EQ27026254-92097314-74D8-4130-AAB1-E154CF6E0919Q28729108-951188E7-E3DB-4C4F-80A6-E470F69C87E9Q30245146-0B51CA8D-7788-4E55-846F-87EB68ACB456Q30373100-68254974-5150-47A7-BEE3-71E8D200D841Q30463103-985C3DD1-BCDC-4D6E-A019-DE7ED8F75F96Q30475737-E39B5DCF-957C-4FA3-8930-D7985DE84330Q30967370-7A3F8700-8A25-41A0-AFB0-70D3AA98E098Q30988178-A7790B5C-F811-4469-A13D-7424F8466293Q30989913-1A5F4144-C520-4610-B92E-E0B2880C6346Q31016200-2C3FFBCB-8006-459C-BE1E-4DD58F154524Q31139548-F6EA6769-A7BE-4E99-8702-2F65C58DAAFCQ33399939-92D0F109-6667-4CE4-9C99-7B578FA47970Q33447142-FC48820E-C178-4ECC-A018-3CCB27C6380DQ33703639-96096EF7-9E25-47EB-9B99-3C5D8FB10159Q33729213-19BE4408-5A78-43B5-965E-793C51E1A977Q33854863-45B8C82A-FFAB-4DEC-99A1-642F5092F706Q33875985-252C2DB8-D1CA-41C8-9456-D69DAC253837Q33894486-32D050A9-95BC-460D-9D87-2338B7EC903FQ34094919-E3A890AA-BB0C-4B1E-9326-18C92200DBA0Q34117487-C2D6F6F4-0FCE-48AB-BEFA-E25B345CAEB7Q34480589-DBB908BC-268C-473F-8D39-C8A82A9B342BQ34570841-A49D8D3E-2B6E-4289-9BF7-03B2C9D21A15Q34785423-56D701EA-E025-4E7E-90B2-33FFD73536C8Q34830708-CDFA5D55-B9E6-4F57-97C9-4414D3B760CEQ34903950-014EDBCE-81FA-4FE3-9B76-3D301459CD2BQ35034643-9D8DC7D1-5AD1-43B2-8929-6D1D6BB89E5BQ35085561-342364E1-3D99-49F7-A4BC-279CE81F14F2Q35678312-D41C81DE-D33C-4CE7-A09D-94707A927BCBQ35788981-27AED573-AFA7-4947-873B-750C49E323FAQ35845266-EBD7EE9B-7A33-4B55-B80B-770B5ECACA47Q36076831-063A3171-F234-4FCE-8BF8-3F2E4218715BQ36198598-74A6D0EA-135C-4DAE-BBFA-EE70448A0A3CQ36307794-9BF6855A-F5D5-40BF-AB76-64E666D2CB0AQ36381656-DE392AB4-16AB-4578-A8F8-B5F5E7477E96Q36409030-0D81B6D2-753F-4EBE-B948-BB896A64E7BEQ36510818-0174F3A8-1A9D-46F0-9593-FF6A39F53DF8Q36608763-5640364E-5FCB-4B7F-94A6-2A2B0FE74A06
P2860
Continuous growth of mean tumor diameter in a subset of grade II gliomas.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Continuous growth of mean tumor diameter in a subset of grade II gliomas.
@en
Continuous growth of mean tumor diameter in a subset of grade II gliomas.
@nl
type
label
Continuous growth of mean tumor diameter in a subset of grade II gliomas.
@en
Continuous growth of mean tumor diameter in a subset of grade II gliomas.
@nl
prefLabel
Continuous growth of mean tumor diameter in a subset of grade II gliomas.
@en
Continuous growth of mean tumor diameter in a subset of grade II gliomas.
@nl
P2093
P356
P1433
P1476
Continuous growth of mean tumor diameter in a subset of grade II gliomas.
@en
P2093
Antoine F Carpentier
Ellsworth C Alvord
Emmanuel Mandonnet
Hugues Duffau
Jean-Yves Delattre
Kristin R Swanson
Laurent Capelle
Marie-Laure Tanguy
Philippe Cornu
Rémy Van Effenterre
P304
P356
10.1002/ANA.10528
P577
2003-04-01T00:00:00Z